✦ LIBER ✦

A POSTOPERATIVE PROGNOSTIC NOMOGRAM FOR RENAL CELL CARCINOMA

✍ Scribed by KATTAN, MICHAEL W.; REUTER, VICTOR; MOTZER, ROBERT J.; KATZ, JARED; RUSSO, PAUL

Book ID: 122393130
Publisher: Lippincott Williams and Wilkins
Year: 2001
Tongue: English
Weight: 81 KB
Volume: 166
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(05)66077-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A POSTOPERATIVE PROGNOSTIC NOMOGRAM PRED

A POSTOPERATIVE PROGNOSTIC NOMOGRAM PREDICTING RECURRENCE FOR PATIENTS WITH CONVENTIONAL CLEAR CELL RENAL CELL CARCINOMA

✍ SORBELLINI, MAXIMILIANO; KATTAN, MICHAEL W.; SNYDER, MARK E.; REUTER, VICTOR; MO 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 83 KB

POSTOPERATIVE SURVEILLANCE PROTOCOL FOR

POSTOPERATIVE SURVEILLANCE PROTOCOL FOR PATIENTS WITH LOCALIZED AND LOCALLY ADVANCED RENAL CELL CARCINOMA BASED ON A VALIDATED PROGNOSTIC NOMOGRAM AND RISK GROUP STRATIFICATION SYSTEM

✍ LAM, JOHN S.; SHVARTS, OLEG; LEPPERT, JOHN T.; PANTUCK, ALLAN J.; FIGLIN, ROBERT 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 421 KB

Prognostic variables and nomograms for r

Prognostic variables and nomograms for renal cell carcinoma

✍ Robert C Flanigan; Anthony J Polcari; Cory M Hugen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB

505 EXTERNAL VALIDATION OF KARAKIEWICZ P

505 EXTERNAL VALIDATION OF KARAKIEWICZ PREOPERATIVE AND POSTOPERATIVE PROGNOSTIC NOMOGRAMS FOR RENAL CELL CARCINOMA.

✍ L. Cindolo; P. Chiodini; O. De Cobelli; S. Brookman-May; L. Santoro; M. May; C. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Nomograms for renal cell carcinoma

✍ Fray F. Marshall 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB

Prognostic nomogram for sunitinib in pat

Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma

✍ Robert J. Motzer; Ronald M. Bukowski; Robert A. Figlin; Thomas E. Hutson; M. Dro 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 3 views

## Abstract ## BACKGROUND. In a randomized, phase 3 trial, sunitinib demonstrated superior efficacy over interferon‐alfa as first‐line therapy in patients with metastatic clear‐cell renal cell carcinoma (RCC). On the basis of outcome data from that trial, the authors developed a nomogram for predi